Scientists from The University of Manchester and Northern Care Alliance NHS Foundation Trust have discovered that the combination of two biomarkers can reliably identify sarcopenia, a serious condition of the muscle linked to higher mortality in chronic kidney disease (CKD). The test, say the researchers, could identify individuals at risk of the condition which is typified by loss of muscle mass and strength as well as an overall poorer quality of life.